• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度肾功能不全患者房颤导管消融术后血清硫酸吲哚酚与肾功能的关系

The relationship between serum indoxyl sulfate and the renal function after catheter ablation of atrial fibrillation in patients with mild renal dysfunction.

作者信息

Koike Hideki, Morita Toshisuke, Tatebe Junko, Watanabe Ippei, Koike Makiko, Yao Shintaro, Shinohara Masaya, Yuzawa Hitomi, Suzuki Takeya, Fujino Tadashi, Ikeda Takanori

机构信息

Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Tokyo, Japan.

Department of Laboratory Medicine, Toho University Faculty of Medicine, 6-11-1 Omorinishi, Ota-ku, Tokyo, 143-8541, Japan.

出版信息

Heart Vessels. 2019 Apr;34(4):641-649. doi: 10.1007/s00380-018-1288-0. Epub 2018 Nov 8.

DOI:10.1007/s00380-018-1288-0
PMID:30406286
Abstract

Indoxyl sulfate (IS), a protein-bound uremic toxin, induces renal disorders and atrial fibrillation (AF). It is well known that renal dysfunction is a risk factor for AF and radiofrequency catheter ablation (RFCA) improves the renal function. However, the improvement in the renal function after RFCA in patients with early stage chronic kidney disease (CKD) and the serial changes in the IS level have not been fully elucidated. This study aimed to investigate whether IS affects the improvement in the renal function. A total of 91 consecutive patients with mild kidney dysfunction (CKD stage I-II) who underwent RFCA and maintained sinus rhythm were prospectively enrolled. The plasma IS level and estimated glomerular filtration rate (eGFR) were determined before, 3 months, and 1 year after RFCA. The patients were divided according to the IS quartiles (Q1-4; < 0.4, 0.4-0.7, 0.7-1.2, and > 1.2 μg/ml). There was no significant difference in the eGFR among the IS quartiles. A significantly higher eGFR improvement rate was obtained for IS-Q4 than the other quartiles (p = 0.039). The IS-Q4 IS level significantly decreased at 1 year after RFCA (1.8 ± 0.8 to 1.2 ± 0.7 μg/ml, p < 0.01). The multivariable logistic model revealed that a high-IS level (IS-Q4) was an independent predictor of an eGFR improvement (OR 3.33; 95% CI 1.16-9.59; p = 0.026). A high-IS level reduction after RFCA improved the renal function in AF patients with mild kidney dysfunction.

摘要

硫酸吲哚酚(IS)是一种与蛋白结合的尿毒症毒素,可引发肾脏疾病和心房颤动(AF)。众所周知,肾功能不全是房颤的一个危险因素,而射频导管消融术(RFCA)可改善肾功能。然而,早期慢性肾脏病(CKD)患者RFCA术后肾功能的改善情况以及IS水平的系列变化尚未完全阐明。本研究旨在探讨IS是否影响肾功能的改善。前瞻性纳入了91例连续接受RFCA且维持窦性心律的轻度肾功能不全(CKD Ⅰ-Ⅱ期)患者。在RFCA术前、术后3个月和1年测定血浆IS水平和估算肾小球滤过率(eGFR)。根据IS四分位数(Q1-4;<0.4、0.4-0.7、0.7-1.2和>1.2μg/ml)对患者进行分组。各IS四分位数组间的eGFR无显著差异。IS-Q4组的eGFR改善率显著高于其他四分位数组(p = 0.039)。RFCA术后1年,IS-Q4组的IS水平显著降低(从1.8±0.8降至1.2±0.7μg/ml,p<0.01)。多变量逻辑模型显示,高IS水平(IS-Q4)是eGFR改善的独立预测因素(OR 3.33;95%CI 1.16-9.59;p = 0.026)。RFCA术后高IS水平的降低改善了轻度肾功能不全房颤患者的肾功能。

相似文献

1
The relationship between serum indoxyl sulfate and the renal function after catheter ablation of atrial fibrillation in patients with mild renal dysfunction.轻度肾功能不全患者房颤导管消融术后血清硫酸吲哚酚与肾功能的关系
Heart Vessels. 2019 Apr;34(4):641-649. doi: 10.1007/s00380-018-1288-0. Epub 2018 Nov 8.
2
The Difference in the Changes of Indoxyl Sulfate after Catheter Ablation among Atrial Fibrillation Patients with and without Kidney Dysfunction.伴有和不伴有肾功能障碍的房颤患者在行导管消融术后硫酸吲哚酚变化的差异。
Sci Rep. 2020 Jan 16;10(1):513. doi: 10.1038/s41598-020-57421-z.
3
Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.肾功和房颤导管消融患者的预后:广州房颤消融登记研究。
Arch Cardiovasc Dis. 2019 Jun-Jul;112(6-7):420-429. doi: 10.1016/j.acvd.2019.02.006. Epub 2019 May 25.
4
Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation.慢性肾脏病患者接受房颤导管消融术后估算肾小球滤过率的改善
J Cardiovasc Electrophysiol. 2015 Jan;26(1):21-7. doi: 10.1111/jce.12530. Epub 2014 Sep 26.
5
Impact of Renal Dysfunction on Left Atrial Structural Remodeling and Recurrence After Catheter Ablation for Atrial Fibrillation - A Propensity Score Matching Analysis.肾功能不全对房颤导管消融后左房结构重构及复发的影响——倾向评分匹配分析。
Circ J. 2020 Jul 22;84(8):1254-1260. doi: 10.1253/circj.CJ-20-0149. Epub 2020 Jul 1.
6
Impaired renal function is associated with recurrence after cryoballoon catheter ablation for paroxysmal atrial fibrillation: A potential effect of non-pulmonary vein foci.肾功能受损与阵发性心房颤动冷冻球囊导管消融术后复发相关:非肺静脉病灶的潜在影响。
J Cardiol. 2017 Jan;69(1):3-10. doi: 10.1016/j.jjcc.2016.07.008. Epub 2016 Aug 5.
7
Renal function after catheter ablation of atrial fibrillation.房颤导管消融术后的肾功能。
Circulation. 2011 Nov 29;124(22):2380-7. doi: 10.1161/CIRCULATIONAHA.111.047266. Epub 2011 Oct 31.
8
Improvement in renal and endothelial function after catheter ablation in patients with persistent atrial fibrillation.持续性心房颤动患者导管消融术后肾和内皮功能的改善。
J Cardiol. 2020 Dec;76(6):610-617. doi: 10.1016/j.jjcc.2020.07.002. Epub 2020 Jul 15.
9
Five-Year Change in the Renal Function After Catheter Ablation of Atrial Fibrillation.房颤导管消融术后 5 年肾功能变化。
J Am Heart Assoc. 2019 Sep 3;8(17):e013204. doi: 10.1161/JAHA.119.013204. Epub 2019 Aug 31.
10
Changes in Left Atrial Transport Function in Patients Who Maintained Sinus Rhythm After Successful Radiofrequency Catheter Ablation for Atrial Fibrillation: A 1-Year Follow-Up Multislice Computed Tomography Study.房颤患者成功进行射频导管消融术后维持窦性心律患者左心房运输功能的变化:一项为期1年的多层螺旋计算机断层扫描随访研究。
J Cardiovasc Electrophysiol. 2017 Feb;28(2):167-176. doi: 10.1111/jce.13128. Epub 2016 Dec 15.

引用本文的文献

1
Analysis of indoxyl sulfate in biological fluids with emphasis on sample preparation techniques: A comprehensive analytical review.生物流体中硫酸吲哚酚的分析:重点关注样品制备技术——综合分析综述
Heliyon. 2024 Jul 23;10(15):e35032. doi: 10.1016/j.heliyon.2024.e35032. eCollection 2024 Aug 15.
2
Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases.肠道微生物群在心血管疾病发病机制中的作用的机制综述。
Cardiovasc Hematol Disord Drug Targets. 2024;24(1):13-39. doi: 10.2174/011871529X310857240607103028.
3
Gut Microbiota and Atrial Fibrillation: Pathogenesis, Mechanisms and Therapies.

本文引用的文献

1
Indoles - Gut Bacteria Metabolites of Tryptophan with Pharmacotherapeutic Potential.吲哚——色氨酸的肠道细菌代谢产物,具有药物治疗潜力。
Curr Drug Metab. 2018;19(10):883-890. doi: 10.2174/1389200219666180427164731.
2
Indole and indoxyl sulfate, gut bacteria metabolites of tryptophan, change arterial blood pressure via peripheral and central mechanisms in rats.色氨酸的肠道细菌代谢产物吲哚和吲哚硫酸,通过大鼠外周和中枢机制改变动脉血压。
Pharmacol Res. 2018 Apr;130:172-179. doi: 10.1016/j.phrs.2017.12.025. Epub 2017 Dec 26.
3
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
肠道微生物群与心房颤动:发病机制、作用机制及治疗方法
Arrhythm Electrophysiol Rev. 2023 Apr 19;12:e14. doi: 10.15420/aer.2022.33. eCollection 2023.
4
Gut microbiota and cardiac arrhythmia: a pharmacokinetic scope.肠道微生物群与心律失常:药代动力学视角
Egypt Heart J. 2022 Dec 30;74(1):87. doi: 10.1186/s43044-022-00325-2.
5
Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease.肠道菌群衍生代谢产物影响心血管疾病的发生发展。
J Multidiscip Healthc. 2022 Nov 9;15:2591-2603. doi: 10.2147/JMDH.S367591. eCollection 2022.
6
Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.肠道微生物群、菌群失调与心房颤动。致心律失常机制及潜在临床意义。
Cardiovasc Res. 2022 Aug 24;118(11):2415-2427. doi: 10.1093/cvr/cvab292.
7
Gut microbial composition in patients with atrial fibrillation: effects of diet and drugs.房颤患者的肠道微生物组成:饮食和药物的影响。
Heart Vessels. 2021 Jan;36(1):105-114. doi: 10.1007/s00380-020-01669-y. Epub 2020 Jul 18.
8
Five-Year Change in the Renal Function After Catheter Ablation of Atrial Fibrillation.房颤导管消融术后 5 年肾功能变化。
J Am Heart Assoc. 2019 Sep 3;8(17):e013204. doi: 10.1161/JAHA.119.013204. Epub 2019 Aug 31.
2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Europace. 2016 Nov;18(11):1609-1678. doi: 10.1093/europace/euw295. Epub 2016 Aug 27.
4
Role of Indoxyl Sulfate as a Predisposing Factor for Atrial Fibrillation in Renal Dysfunction.硫酸吲哚酚作为肾功能不全时心房颤动诱发因素的作用
J Am Heart Assoc. 2015 Oct 9;4(10):e002023. doi: 10.1161/JAHA.115.002023.
5
The uremic toxin indoxyl sulfate increases pulmonary vein and atrial arrhythmogenesis.尿毒症毒素硫酸吲哚酚会增加肺静脉和心房心律失常的发生。
J Cardiovasc Electrophysiol. 2015 Feb;26(2):203-10. doi: 10.1111/jce.12554. Epub 2014 Nov 4.
6
Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation.慢性肾脏病患者接受房颤导管消融术后估算肾小球滤过率的改善
J Cardiovasc Electrophysiol. 2015 Jan;26(1):21-7. doi: 10.1111/jce.12530. Epub 2014 Sep 26.
7
Plasma indoxyl sulfate and estimated glomerular filtration rate.血浆硫酸吲哚酚与估计肾小球滤过率
Circ J. 2014;78(10):2477-82. doi: 10.1253/circj.cj-14-0401. Epub 2014 Aug 11.
8
Cardiovascular magnetic resonance demonstrates reversible atrial dysfunction after catheter ablation of persistent atrial fibrillation.心血管磁共振显示持续性心房颤动导管消融后心房功能可逆。
J Cardiovasc Electrophysiol. 2013 Jul;24(7):762-7. doi: 10.1111/jce.12125. Epub 2013 Mar 29.
9
Significant improvement of left atrial and left atrial appendage function after catheter ablation for persistent atrial fibrillation.持续性心房颤动导管消融术后左心房和左心耳功能的显著改善。
Circ J. 2013;77(7):1695-704. doi: 10.1253/circj.cj-12-1518. Epub 2013 Mar 26.
10
Decreased glomerular filtration rate and markers of left atrial stasis in patients with nonvalvular atrial fibrillation.非瓣膜性心房颤动患者肾小球滤过率降低及左心房淤血标志物
Cardiology. 2013;124(1):3-10. doi: 10.1159/000345434. Epub 2012 Dec 13.